Gene · 2050
Papers2,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Delineation of the phenotypes and genotypes of facial infiltrating lipomatosis associated with PIK3CA mutations. | Orphanet J Rare Dis | 2023 | 37452404 | PubTator, text mining | PubMed |
| Unraveling the Significance of EPH/Ephrin Signaling in Liver Cancer: Insights into Tumor Progression and Therapeutic Implications. | Cancers (Basel) | 2023 | 37444544 | PubTator, text mining | PubMed |
| The DTX Protein Family: An Emerging Set of E3 Ubiquitin Ligases in Cancer. | Cells | 2023 | 37443713 | PubTator, text mining | PubMed |
| Cytogenomic Investigation of Syndromic Brazilian Patients with Differences of Sexual Development. | Diagnostics (Basel) | 2023 | 37443631 | PubTator, text mining | PubMed |
| Extracellular matrix cues regulate the differentiation of pluripotent stem cell-derived endothelial cells. | Front Cardiovasc Med | 2023 | 37435057 | PubTator, text mining | PubMed |
| Tumor-associated myeloid cells in cancer immunotherapy. | J Hematol Oncol | 2023 | 37415162 | PubTator, text mining | PubMed |
| The Eph/Ephrin system in primary bone tumor and bone cancer pain. | Aging (Albany NY) | 2023 | 37413995 | PubTator, text mining | PubMed |
| Proteomic profiling of longitudinal changes in kidney function among middle-aged and older men and women: the KORA S4/F4/FF4 study. | BMC Med | 2023 | 37407978 | PubTator, text mining | PubMed |
| Tenascin-C in Tissue Repair after Myocardial Infarction in Humans. | Int J Mol Sci | 2023 | 37373332 | PubTator, text mining | PubMed |
| Mass Spectrometry and Pharmacological Approaches to Measuring Cooption and Reciprocal Activation of Receptor Tyrosine Kinases. | Proteomes | 2023 | 37368466 | PubTator, text mining | PubMed |
| NDRG3 regulates imatinib resistance by promoting β‑catenin accumulation in the nucleus in chronic myelogenous leukemia. | Oncol Rep | 2023 | 37350410 | PubTator, text mining | PubMed |
| Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer. | Front Oncol | 2023 | 37346077 | PubTator, text mining | PubMed |
| Genetically engineering endothelial niche in human kidney organoids enables multilineage maturation, vascularization and de novo cell types. | bioRxiv | 2023 | 37333155 | PubTator, text mining | PubMed |
| Proteomics of novel induced pluripotent stem cell-derived vascular endothelial cells reveal extensive similarity with an immortalized human endothelial cell line. | Physiol Genomics | 2023 | 37306406 | PubTator, text mining | PubMed |
| Precision Medicine to Treat Urothelial Carcinoma-The Way Forward. | Cancers (Basel) | 2023 | 37296985 | PubTator, text mining | PubMed |
| Prevascularization techniques for dental pulp regeneration: potential cell sources, intercellular communication and construction strategies. | Front Bioeng Biotechnol | 2023 | 37274160 | PubTator, text mining | PubMed |
| Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases. | Front Neurol | 2023 | 37273690 | PubTator, text mining | PubMed |
| EPHB4-RASA1-Mediated Negative Regulation of Ras-MAPK Signaling in the Vasculature: Implications for the Treatment of EPHB4- and RASA1-Related Vascular Anomalies in Humans. | Pharmaceuticals (Basel) | 2023 | 37259315 | PubTator, text mining | PubMed |
| PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling. | Cell Rep | 2023 | 37243593 | PubTator, text mining | PubMed |
| Nanoparticle-Based Radioconjugates for Targeted Imaging and Therapy of Prostate Cancer. | Molecules | 2023 | 37241862 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2050/papers?page=13